
Thomas LeBlanc, MD
Duke Cancer Institute
Conference Co-Chair
Biography
Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO is Associate Professor of Medicine with Tenure in the Division of Hematologic Malignancies and Cellular Therapy (HMCT) at the Duke University School of Medicine, and founding Director of the Cancer Patient Experience Research Program (CPEP) in the Duke Cancer Institute (DCI). He serves as the Chief Patient Experience and Safety Officer for the DCI, and the Director of Outcomes Research for the Division of HMCT. Dr. LeBlanc is board-certified in medical oncology and in hospice and palliative medicine, and his practice focuses on the care of patients with blood cancers, particularly those with acute leukemias and myeloid malignancies. His program of research focuses on palliative care and patient experience issues in hematology.
Financial Disclosure
Pfizer
Professional Services
Gilead
Professional Services
Lilly
Professional Services
Novartis
Professional Services
Astellas
Professional Services
Taiho
Professional Services
GSK
Professional Services
Syndax
Professional Services
Jazz
Grant Or Contract
Rigel
Professional Services
BMS/Celgene
Professional Services
Novo Nordisk
Professional Services
Menarini-Stemline
Professional Services
Geron
Professional Services
DosenTrx
Stock Options
ThymeCare
Stock Options
AbbVie/Genentech
Professional Services
Agios/Servier
Professional Services
UpToDate Inc.
Professional Services